CRP and metabolic dysfunction-associated steatohepatitis: We have shown that IL6-stimulated CRP and hepcidin expression in adipose tissue is associated with the elevated circulating levels of CRP and hypoferremia in morbidly obese patients independently of NASH [10]–[12].